Last updated: February 24, 2026
What is NDC 69367-0269?
NDC 69367-0269 corresponds to Oxygen (liquid) marketed primarily as a medical gas for respiratory therapy. The product is used in hospitals, clinics, and for home healthcare. It is supplied in liquid form, requiring vaporization for medical use.
Product Details and Market Context
| Parameter |
Details |
| Form |
Liquid oxygen (LOX) |
| Packaging |
Typically stored in cryogenic tanks or cylinders |
| Indications |
Hypoxemia, respiratory distress, anesthesia |
| Manufacturing |
Multiple suppliers, including Air Liquide, Linde, Praxair |
| Regulatory Status |
FDA approved for medical use |
Liquid oxygen is categorized under medical gases, with a market size driven by oxygen therapy needs, growth in respiratory diseases, and expanded use in emergency services.
Market Size and Trends
1. Global Market Value
In 2021, the global medical oxygen market was valued at approximately $6.2 billion, with a compound annual growth rate (CAGR) of around 7% from 2016 to 2021. The segment for liquid oxygen comprises roughly 30-40% of this market, reflecting increased hospital, home healthcare, and emergency service demand [1].
2. Regional Market Breakdown
| Region |
Market Share (2021) |
Key Drivers |
| North America |
45% |
Robust healthcare infrastructure, COVID-19 impact |
| Europe |
25% |
Aging populations, respiratory disease prevalence |
| Asia-Pacific |
20% |
Growing healthcare access, industrialization |
| Others |
10% |
Expanding infrastructure, government initiatives |
3. Key Drivers
- Increasing incidences of chronic obstructive pulmonary disease (COPD), pneumonia, and COVID-19-related respiratory complications.
- Expansion of home oxygen therapy.
- Technological advancements lowering operational costs.
- Policy shifts supporting non-invasive oxygen therapy.
4. Competitive Landscape
Major suppliers include:
- Linde plc
- Air Liquide
- Praxair (a part of Linde)
- Air Products
These firms hold significant market share due to their advanced cryogenic technologies, extensive distribution networks, and established regulatory compliance.
Price Analysis and Projection
1. Current Pricing
| Region |
Approximate Price per Cubic Meter |
Notes |
| North America |
$2.50 – $4.00 |
Varies with supply chain, transportation, and volume discounts |
| Europe |
$2.80 – $4.50 |
Dependent on local regulations and logistics |
| Asia-Pacific |
$2.00 – $3.50 |
Lower costs due to manufacturing and labor |
Prices are affected by:
- Production costs, especially cryogenic plant operation.
- Transportation and storage logistics.
- Volume discounts for large healthcare providers.
2. Price Trends (2022-2027)
- Stable Prices (2022-2024): Slight decline due to technological efficiency improvements and increased local production.
- Potential Price Rise (Post-2024): Prices may increase by 5-8% driven by inflation, supply chain disruptions, and increased demand for oxygen during health crises.
3. Price Sensitivity Factors
- Volume: Bulk purchasing reduces per-unit costs.
- Regulatory environments: Stringent safety standards increase operational costs, affecting final prices.
- Market disruptions: Pandemics like COVID-19 temporarily boost demand, stabilizing or increasing prices.
Regulatory and Policy Impact
- FDA Regulation: Ensures safety and quality but requires compliance that can influence production costs.
- Reimbursement policies: In the U.S., CMS reimbursement structures influence hospital procurement and pricing strategies.
Key Challenges
- Supply chain disruptions due to global logistics issues.
- Fluctuating demand driven by pandemic waves or seasonal respiratory illnesses.
- Competition driving price compression, especially with emerging local manufacturing.
Future Outlook
| Aspect |
Projection |
| Market Growth Rate |
6-8% annually from 2022 through 2027 |
| Price Trajectory |
Slight decline in unit cost followed by stabilization; overall revenue may increase with expanding demand |
| Market Expansion Opportunities |
Home healthcare, developing countries, emergency response integration |
Summarized Investment and R&D Trends
- Rising investment in cryogenic storage technology.
- R&D for more efficient oxygen production processes.
- Entry of regional players improving market competitiveness.
Key Takeaways
- The liquid oxygen market is projected to grow at a CAGR of 6-8%.
- Current prices vary regionally, averaging $2.50–$4.50 per cubic meter.
- Pricing stability is expected in the short term, with potential increases post-2024.
- Major players maintain dominance through technological advances and extensive logistics.
- Regulatory, supply chain, and demand fluctuations remain key risk factors.
FAQs
Q1: How does the price of liquid oxygen compare to other forms?
Liquid oxygen prices are generally higher than gaseous oxygen due to storage and transportation requirements but offer cost efficiencies for large-volume and hospital use.
Q2: Which regions offer the most growth opportunities?
Asia-Pacific and emerging markets in Africa and Latin America present significant growth potential due to expanding healthcare infrastructure.
Q3: What factors influence the supply stability of liquid oxygen?
Supply depends on cryogenic plant capacity, transportation logistics, regional regulations, and global supply chain stability.
Q4: How are technological developments affecting prices?
Innovations in oxygen generation and storage reduce operational costs, leading to overall price stabilization and potential decreases.
Q5: What is the impact of COVID-19 on the liquid oxygen market?
The pandemic increased demand for oxygen, boosting prices temporarily and prompting new investments in production capacity.
References
[1] MarketsandMarkets. (2022). Medical oxygen market size and forecast. Retrieved from https://www.marketsandmarkets.com
